Insider Transactions Reported by 16 Insiders of ORAMED PHARMACEUTICALS INC.

Symbol
ORMP on Nasdaq
Location
New York, NY

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

ORAMED PHARMACEUTICALS INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Nadav Kidron President and CEO, Director $10,319,104 12 Mar 2026
Benjamin Shapiro Director $6,150,588 31 Dec 2025
Miriam Kidron Chief Scientific Officer, Director $4,128,692 22 Jan 2026
Joshua Hexter Coo & Cbo $3,033,810 22 Jan 2026
Avraham Gabay Chief Financial Officer $1,850,379 22 Jan 2026
David Silberman Chief Financial Officer $809,965 04 Jan 2024
Arie Mayer Director $510,747 31 Dec 2025
Daniel Aghion Director $344,860 31 Dec 2025
Yadin Rozov Director $343,257 04 Jan 2024
Netanel Derovan Chief Legal Officer $330,395 26 May 2023
Yehuda Reznick Director $319,747 31 Dec 2025
Leonard Sank Director $301,349 05 Jun 2025
Michael Rabinowitz Chief Commercial Officer $278,776 03 Jan 2023
Michael Rabinowitz Chief Commercial Officer $241,924 03 Jan 2022
Kevin Rakin Director $103,121 21 Mar 2022
Aviad Friedman Director 03 Jan 2022

Recent Insider Transactions by Companies or Individuals for ORAMED PHARMACEUTICALS INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Nadav Kidron ORMP Common Stock Gift -2.98% -100,000 3,255,238 12 Mar 2026 Direct
Nadav Kidron ORMP Common Stock Options Exercise 3.36% 109,000 3,355,238 22 Jan 2026 Direct
Nadav Kidron ORMP Performance Stock Units Options Exercise -100% -109,000 0 22 Jan 2026 Direct
Miriam Kidron ORMP Common Stock Options Exercise 1.33% 19,000 1,448,664 22 Jan 2026 Direct
Miriam Kidron ORMP Performance Stock Units Options Exercise -100% -19,000 0 22 Jan 2026 Direct
Joshua Hexter ORMP Common Stock Options Exercise 1.82% 19,000 1,064,495 22 Jan 2026 Direct
Joshua Hexter ORMP Performance Stock Units Options Exercise -100% -19,000 0 22 Jan 2026 Direct
Avraham Gabay ORMP Common Stock Options Exercise 3.01% 19,000 649,256 22 Jan 2026 Direct
Avraham Gabay ORMP Performance Stock Units Options Exercise -100% -19,000 0 22 Jan 2026 Direct
Miriam Kidron ORMP Common Stock Gift -6.03% -86,166 1,343,498 14 Jan 2026 Direct
Yehuda Reznick ORMP Common Stock Award 52.6% 36,250 105,180 31 Dec 2025 Direct
Nadav Kidron ORMP Common Stock Award 20.8% 559,640 3,246,238 31 Dec 2025 Direct
Nadav Kidron ORMP Performance Stock Units Award 109,000 109,000 31 Dec 2025 Direct
Miriam Kidron ORMP Common Stock Award 19.8% 236,331 1,429,664 31 Dec 2025 Direct
Miriam Kidron ORMP Performance Stock Units Award 19,000 19,000 31 Dec 2025 Direct
Joshua Hexter ORMP Common Stock Award 25.5% 212,328 1,045,495 31 Dec 2025 Direct
Joshua Hexter ORMP Performance Stock Units Award 19,000 19,000 31 Dec 2025 Direct
Benjamin Shapiro ORMP Common Stock Award 37.3% 33,500 123,220 31 Dec 2025 Direct
Arie Mayer ORMP Common Stock Award 26.2% 34,900 168,009 31 Dec 2025 Direct
Daniel Aghion ORMP Common Stock Award 47% 36,250 113,441 31 Dec 2025 Direct
Avraham Gabay ORMP Common Stock Award 45.2% 196,216 630,256 31 Dec 2025 Direct
Avraham Gabay ORMP Performance Stock Units Award 19,000 19,000 31 Dec 2025 Direct
Arie Mayer ORMP Common Stock Award 38.5% 36,975 133,109 05 Jun 2025 Direct
Daniel Aghion ORMP Common Stock Award 98.8% 38,371 77,191 05 Jun 2025 Direct
Yehuda Reznick ORMP Common Stock Award 125.6% 38,370 68,930 05 Jun 2025 Direct
Leonard Sank ORMP Common Stock Award 37.2% 36,510 134,531 05 Jun 2025 Direct
Benjamin Shapiro ORMP Common Stock Award 62.9% 34,650 89,720 05 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.